Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women

Menopause

Volumn 21, Issue 1, 2014, Pages 67-73

  Lee, Hee Jun ^a   Kim, Hoon ^a   Ku, Seung Yup ^a,b   Choi, Young Min ^a,b   Kim, Jong Hak ^b   Kim, Jung Gu ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

Author keywords

A Adrenergic receptor; Bone density; Bone markers.; Leptin; Polymorphism

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BETA ADRENERGIC RECEPTOR; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; LEPTIN RECEPTOR; OSTEOPROTEGERIN;

ADULT; AGED; ALLELE; ARTICLE; BONE DENSITY; BONE TURNOVER; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; FEMUR NECK; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HORMONE BLOOD LEVEL; HUMAN; KOREAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MIDDLE AGED; OSTEOPOROSIS; PHENOTYPE; POSTMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALKALINE PHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BONE DENSITY; COLLAGEN TYPE I; FEMALE; FEMUR NECK; GENOTYPE; HUMANS; LEPTIN; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPROTEGERIN; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RANK LIGAND; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; RECEPTORS, LEPTIN; REPUBLIC OF KOREA;

EID: 84891835755     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31829366ed     Document Type: Article

References (42)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-795.
2. Jouanny P, Guillemin F, Kuntz C, Jeandel C, Pourel J. Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families. Arthritis Rheum 1995;38:61-67.
3. Kim H, Choe SA, Ku SY, Kim SH, Kim JG. Association between Wnt signaling pathway gene polymorphisms and bone response to hormone therapy in postmenopausal Korean women. Menopause 2011;18:808-813.
4. Kim H, Chun S, Ku SY, Suh CS, Choi YM, Kim JG. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women. Menopause 2009;16:1014-1020.
5. Kim JG, Kim JH, Kim JY, et al. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-JB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause 2007;14:913-918.
6. Kim JG, Kwon JH, Kim SH, Choi YM, Moon SY, Lee JY. Association between vitamin D receptor gene haplotypes and bone mass in postmenopausal Korean women. Am J Obstet Gynecol 2003;189:1234-1240.
7. Kim JG, Lim KS, Kim EK, Choi YM, Lee JY. Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women. Menopause 2001;8:222-228.
8. Kim JG, Roh KR, Lee JY. The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism, and bone mineral density in postmenopausal women in Korea. Am J Obstet Gynecol 2002;186:345-350.
9. Hamrick MW, Ferrari SL. Leptin and the sympathetic connection of fat to bone. Osteoporos Int 2008;19:905-912.
10. Flier JS. Clinical review 94: whats in a name? In search of leptins physiologic role. J Clin Endocrinol Metab 1998;83:1407-1413.
11. Gat-Yablonski G, Ben-Ari T, Shtaif B, et al. Leptin reverses the inhibitory effect of caloric restriction on longitudinal growth. Endocrinology 2004;145:343-350.
12. Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004;351:987-997.
13. Lee NJ, Wong IP, Baldock PA, Herzog H. Leptin as an endocrine signal in bone. Curr Osteoporos Rep 2008;6:62-66.
14. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1998;1:445-450.
15. Elefteriou F, Ahn JD, Takeda S, et al Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005;434:514-520.
16. Crabbe P, Goemaere S, Zmierczak H, Van Pottelbergh I, De Bacquer D, Kaufman JM. Are serum leptin and the Gln223Arg polymorphism of the leptin receptor determinants of bone homeostasis in elderly men? Eur J Endocrinol 2006;154:707-714.
17. Fairbrother UL, Tanko LB, Walley AJ, Christiansen C, Froguel P, Blakemore AI. Leptin receptor genotype at Gln223Arg is associated with body composition, BMD, and vertebral fracture in postmenopausal Danish women. J Bone Miner Res 2007;22:544-550.
18. Kim SM, Kim SH, Lee JR, et al. Association of leptin receptor polymorphisms Lys109Arg and Gln223Arg with serum leptin profile and bone mineral density in Korean women. Am J Obstet Gynecol 2008;198:421 e1-e8.
19. Koh JM, Kim DJ, Hong JS, et al. Estrogen receptor gene polymorphisms Pvu II and Xba I influence association between leptin receptor gene polymorphism (Gln223Arg) and bone mineral density in young men. Eur J Endocrinol 2002;147:777-783.
20. Richert L, Chevalley T, Manen D, Bonjour JP, Rizzoli R, Ferrari S. Bone mass in prepubertal boys is associated with a Gln223Arg amino acid substitution in the leptin receptor. J Clin Endocrinol Metab 2007;92:4380-4386.
21. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
22. Chang TJ, Tsai MH, Jiang YD, et al. The Arg16Gly polymorphism of human A2-adrenoreceptor is associated with type 2 diabetes in Taiwanese people. Clin Endocrinol (Oxf) 2002;57:685-690.
23. Ikarashi T, Hanyu O, Maruyama S, et al. Genotype Gly/Gly of the Arg16Gly polymorphism of the A2-adrenergic receptor is associated with elevated fasting serum insulin concentrations, but not with acute insulin response to glucose, in type 2 diabetic patients. Diabetes Res Clin Pract 2004;63:11-18.
24. Katsumata K, Nishizawa K, Unno A, Fujita Y, Tokita A. Association of gene polymorphisms and bone density in Japanese girls. J Bone Miner Metab 2002;20:164-169.
25. Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML. A2- Adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals. Am J Hypertens 2005;18:1009-1014.
26. Wang CY, Nguyen ND, Morrison NA, Eisman JA, Center JR, Nguyen TV. A3-Adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). BMC Med Genet 2006;7:57.
27. Reid IR. Relationships among body mass, its components, and bone. Bone 2002;31:547-555.
28. De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005;16:1330-1338.
29. Akune T, Ohba S, Kamekura S, et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004;113:846-855.
30. Ogawa T, Hirose H, Yamamoto Y, et al. Relationships between serum soluble leptin receptor level and serumleptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population. Metabolism 2004;53:879-885.
31. Sun Q, Cornelis MC, Kraft P, et al. Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels. Hum Mol Genet 2010;19:1846-1855.
32. Chagnon YC, ChungWK, Perusse L, Chagnon M, Leibel RL, Bouchard C. Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study. Int J Obes Relat Metab Disord 1999;23:278-286.
33. Quinton ND, Lee AJ, Ross RJ, Eastell R, Blakemore AI. A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet 2001;108:233-236.
34. Heo M, Leibel RL, Boyer BB, et al. Pooling analysis of genetic data: the association of leptin receptor (LEPR) polymorphisms with variables related to human adiposity. Genetics 2001;159:1163-1178.
35. Paracchini V, Pedotti P, Taioli E. Genetics of leptin and obesity: a HuGE review. Am J Epidemiol 2005;162:101-114.
36. He JY, Jiang LS, Dai LY. The roles of the sympathetic nervous system in osteoporotic diseases: a review of experimental and clinical studies. Ageing Res Rev 2011;10:253-263.
37. Moore RE, Smith CK II, Bailey CS, Voelkel EF, Tashjian AH Jr. Characterization of A-adrenergic receptors on rat and human osteoblast-like cells and demonstration that A-receptor agonists can stimulate bone resorption in organ culture. Bone Miner 1993;23:301-315.
38. Takeuchi T, Tsuboi T, Arai M, Togari A. Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol 2001;61:579-586.
39. Litonjua AA, Gong L, Duan QL, et al. Very important pharmacogene summary ADRB2. Pharmacogenet Genomics 2010;20:64-69.
40. Park HS, Shin ES, Lee JE. Genotypes and haplotypes of A2-adrenergic receptor and parameters of the metabolic syndrome in Korean adolescents. Metabolism 2008;57:1064-1070.
41. Suh YJ, Park HJ, Lee KA, Lee BE, Ha EH, Kim YJ. Associations between genetic polymorphisms of A-2 adrenergic receptor and preterm delivery in korean women. Am J Reprod Immunol 2013;69:85-91.
42. Ogawa S, Emi M, Shiraki M, et al. Association of amino acid variation (Trp64Arg) in the A3-adrenergic receptor gene with bone mineral density. Geriatr Gerontol Int 2002;2:138-142